Invesco
PRVA icon

Invesco’s Privia Health PRVA Stock Holding History

Invesco’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
449,755
+19,882
+5% +$461K ﹤0.01% 1821
2026
Q1 		$8.84M Buy
429,873
+2,258
+0.5% +$50.9K ﹤0.01% 1898
2025
Q4 		$10.1M Buy
427,615
+20,652
+5% +$503K ﹤0.01% 1827
2025
Q3 		$10.1M Sell
406,963
-936
-0.2% -$20.1K ﹤0.01% 1817
2025
Q2 		$9.38M Buy
407,899
+18,115
+5% +$419K ﹤0.01% 1816
2025
Q1 		$8.75M Buy
389,784
+15,945
+4% +$370K ﹤0.01% 1855
2024
Q4 		$7.31M Sell
373,839
-55,556
-13% -$1.1M ﹤0.01% 2045
2024
Q3 		$7.82M Sell
429,395
-26,542
-6% -$506K ﹤0.01% 1972
2024
Q2 		$7.92M Sell
455,937
-9,354
-2% -$166K ﹤0.01% 1940
2024
Q1 		$9.12M Sell
465,291
-1,363,612
-75% -$28.8M ﹤0.01% 1871
2023
Q4 		$42.1M Buy
1,828,903
+102,934
+6% +$2.3M 0.01% 1085
2023
Q3 		$39.7M Buy
1,725,969
+47,643
+3% +$1.21M 0.01% 1047
2023
Q2 		$43.8M Buy
1,678,326
+553,528
+49% +$14.6M 0.01% 995
2023
Q1 		$31.1M Buy
1,124,798
+61,819
+6% +$1.63M 0.01% 1153
2022
Q4 		$24.1M Buy
1,062,979
+78,468
+8% +$2.18M 0.01% 1283
2022
Q3 		$33.5M Buy
984,511
+497,661
+102% +$18.4M 0.01% 1063
2022
Q2 		$14.2M Buy
486,850
+456,857
+1,523% +$11.6M ﹤0.01% 1600
2022
Q1 		$802K Buy
29,993
+5,891
+24% +$139K ﹤0.01% 3168
2021
Q4 		$624K Buy
24,102
+1,200
+5% +$29.9K ﹤0.01% 3293
2021
Q3 		$540K Buy
22,902
+17,651
+336% +$616K ﹤0.01% 3397
2021
Q2 		$233K Buy
+5,251
New +$194K ﹤0.01% 3735

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Invesco's PRVA Position: Q2 2026 in Review

Invesco increased its Privia Health (PRVA) stake by 4.6% in Q2 2026, buying an estimated $461K and bringing the position to 449,755 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Invesco first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $43.8M in Q2 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Invesco held 449,755 shares of Privia Health worth $11.6M as of Q2 2026.
  • Invesco bought 19,882 Privia Health shares in Q2 2026, an estimated $461K.
  • Privia Health made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1821 holding.
  • Invesco first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Invesco's Privia Health position peaked at $43.8M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.